No Data
Express News | Creative Medical Technologies Granted US Patent #12642818 Inducing And Accelerating Post-Stroke Recovery By Administration Of Amniotic Fluid Derived Stem Cells
Express News | Creative Medical Tech Q1 EPS $(0.38) Beats $(0.39) Estimate
Creative Medical Technology | 10-Q: Quarterly report
Roth MKM Maintains Creative Medical Technology(CELZ.US) With Buy Rating, Maintains Target Price $20
Creative Medical Knee Data 'Highly Positive,' Says Roth Capital
Creative Medical Technology Announces Results From Pilot Study Of Ultrasome, Proprietary Cell-Free Regenerative Therapy For Treatment Of Osteoarthritis Of Knee